The head of Ozempic maker Novo Nordisk A/S is among business executives who are meeting the Danish prime minister to discuss ...

For a long time, dieting and exercise were the only realistic options for many people who wanted to lose weight, but recent ...

Read full article: Person transported to hospital by helicopter after 6-car crash on highway in ... the burden is put on the ...

GLP-1-based drugs such as semaglutide (Wegovy) and tirzepatide (Mounjaro) work by helping people to feel ... carrying the shopping in from the car in fewer trips and walking at a slightly quicker ...

Imagine feeling stuck—tired, weighed down, and far from the healthiest version of yourself. That’s exactly where I found ...

We recently published an article titled Jim Cramer Discussed These 21 Stocks As Bond Yields Soared. In this article, we are ...

Will hybrid work take more steps back in 2025? It's one of the top questions that could shape the business world in the new year.

When you weigh nearly 20 stone, small everyday things are fraught with anxiety. There are so many worries regular-sized ...

The FDA added that Novo Nordisk's (NOVOb.CO), opens new tab rival weight-loss drug, Wegovy, was still in shortage ... both sides said they were working to agree on a schedule for the case to ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

Semaglutide and tirzepatide are both glucagon-like peptide-1 receptor agonists, known as GLP-1s, that work by telling your ... and their twin versions Wegovy and Zepbound have also helped millions ...